Amgen Inc.
VEGFR-FC FUSION PROTEIN FORMULATIONS
Last updated:
Abstract:
Protein formulations and methods of making and using such formulations are provided herein. The formulation can be an ophthalmic formulation, such as for intravitreal administration. In some embodiments, the formulation comprises a VEGFR-Fc fusion protein, such as aflibercept.
Status:
Application
Type:
Utility
Filling date:
16 Nov 2018
Issue date:
29 Oct 2020